NIPA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.88737914186277E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.39319999981069E-10 |
Normal-vs-Stage2 |
3.87339999996517E-06 |
Normal-vs-Stage3 |
7.74935671188359E-12 |
Normal-vs-Stage4 |
3.67740000006833E-07 |
Stage1-vs-Stage2 |
5.412000E-01 |
Stage1-vs-Stage3 |
1.103220E-01 |
Stage1-vs-Stage4 |
7.382600E-01 |
Stage2-vs-Stage3 |
1.207020E-01 |
Stage2-vs-Stage4 |
8.109800E-01 |
Stage3-vs-Stage4 |
1.591750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62903024403249E-12 |
Normal-vs-AfricanAmerican |
2.73890000013211E-07 |
Normal-vs-Asian |
4.438500E-02 |
Caucasian-vs-AfricanAmerican |
6.275600E-01 |
Caucasian-vs-Asian |
5.688600E-01 |
AfricanAmerican-vs-Asian |
6.983400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.44009282066327E-15 |
Normal-vs-Female |
7.29050153580602E-11 |
Male-vs-Female |
1.055580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.76999999990102E-07 |
Normal-vs-Age(41-60Yrs) |
1.99750216367534E-11 |
Normal-vs-Age(61-80Yrs) |
1.73372427525464E-12 |
Normal-vs-Age(81-100Yrs) |
3.78790000000739E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.348580E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.160010E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.287400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.345400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.096200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.327800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.315600E-03 |
Normal-vs-Grade 2 |
2.09354755753566E-12 |
Normal-vs-Grade 3 |
1.6574519534629E-12 |
Normal-vs-Grade 4 |
3.25569999848341E-08 |
Grade 1-vs-Grade 2 |
9.266800E-01 |
Grade 1-vs-Grade 3 |
6.282400E-01 |
Grade 1-vs-Grade 4 |
8.389400E-01 |
Grade 2-vs-Grade 3 |
2.598000E-01 |
Grade 2-vs-Grade 4 |
7.709800E-01 |
Grade 3-vs-Grade 4 |
6.196400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.24720012095736E-10 |
Normal-vs-ccB subtype |
1.63419999754666E-09 |
ccA subtype-vs-ccB subtype |
4.978400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.27330376745272E-11 |
Normal-vs-N1 |
2.536100E-02 |
N0-vs-N1 |
5.473400E-01 |
|
|